Agilent Technologies and Integrated Diagnostics Enter Strategic Partnership to Develop Protein-Based Assays for Early Disease Detection

Agilent Technologies Inc. (NYSE: A) and Integrated Diagnostics today announced a strategic partnership to develop assays that detect major human diseases at very early stages to improve treatment outcomes.

Source: Agilent Technologies